Praxis Precision Medicines, Inc. · NASDAQ:PRAX
Morgan Stanley reported a 6.20% stake in Praxis Precision Medicines, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 5, 2025
Morgan Stanley reported a 6.20% stake in Praxis Precision Medicines, Inc., 1,157,140 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G).
- Stake
- 6.20%
- Shares
- 1,157,140
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 6.20% | 1,157,140 |
| Morgan Stanley Capital Services LLC | 5.60% | 1,045,291 |
Source
Related
- Praxis Precision Medicines, Inc.
- Morgan Stanley
- Praxis Precision Medicines, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Nov 7, 2025
- Schedule 13G/A · Orbis Investment Management LTD · Aug 14, 2026
- Form 4 · Souza Marcio · Jul 8, 2026
- Form 4 · DeSimone Jill · Jun 26, 2026
- Form 4 · Arbuckle Stuart A · Jun 12, 2026
- Form 4 · Chodakewitz Jeffrey · Jun 12, 2026